[Cutaneopulmonary sarcoidosis during pegylated interferon plus ribavirin therapy]

Gastroenterol Hepatol. 2006 Mar;29(3):150. doi: 10.1157/13085136.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Male
  • Polyethylene Glycols / adverse effects*
  • Recombinant Proteins
  • Ribavirin / adverse effects*
  • Sarcoidosis / chemically induced*
  • Sarcoidosis, Pulmonary / chemically induced*
  • Skin Diseases / chemically induced*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a